Finding the right research article has been made much easier thanks to a new search application developed by Brisbane-based Leximancer and piloted at Needlz for academic and commercial researchers.
UQ students and academics can access Needlz via the SciVerse hub, Scopus and ScienceDirect search results on the UQ library website. A training video is available on the library website, Leximancer website, and YouTube.
Leximancer CEO, Mac Exon-Taylor, said Needlz aimed to save researchers significant time and effort when searching for the right information from multiple sources.
“Needlz demonstrates the power of Leximancer’s proprietary technology to quickly and accurately analyse text, which helps users locate the critical themes of any kind of document much faster than reading every abstract of every title that comes up in a standard search.
“The diversity and volume of research undertaken at The University of Queensland provides an excellent scenario for piloting Needlz with ScienceDirect, which is the largest and most widely accessed database of academic journal articles in the world,” Mr Exon-Taylor said.
“Working with Elsevier and UQ’s library staff had opened up new possibilities for Leximancer-based software to improve the search experience for UQ academics as well as millions of users worldwide.”
Needlz is the latest release from Leximancer, which was established in 2005 by UniQuest, UQ’s main commercialisation company. Leximancer’s current suite of text analytics and customer insight software is used by companies around the world, including more than 100 universities.
UniQuest Managing Director, David Henderson, said that it was fitting for Leximancer to launch Needlz at UQ.
“Leximancer is a company based on technology developed at this university, so it has a keen understanding of what professional researchers need,” Mr Henderson said.
“With the Needlz application, Leximancer continues to offer practical solutions for one of its key markets, while highlighting the growing interest from global industry players in Australian university-based innovation.”
Rafael Sidi, Elsevier’s Vice President of Product Management, Applications Marketplace and Developer Network, said the application was a good example of collaboration between Elsevier, Leximancer and The University of Queensland to provide a new complement in the company’s research platform.
“We are glad that Leximancer chose to use ScienceDirect content to build this solution for The University of Queensland as it will be a valuable work flow solution for the research community,” Mr Sidi said.
While Needlz is exclusively available via the UQ library website for now, a number of other Australian and international organisations have expressed interest in the product for their research communities.
ends
Media enquiries: Leanne Wyvill +61 7 3365 4037, 0409 767 199 or l.wyvill@uniquest.com.au or Mac Exon-Taylor +61 0 400 947 482 or mac@leximancer.com
About Leximancer
Leximancer is an Australian company based in Brisbane, Queensland that has been providing leading-edge text analytics technology since 2005. Leximancer products are being used by leading global companies in Australia, Europe and North America, as well as over 100 academic institutions on every continent. Applications are in market research, defence, government, consulting, insurance, legal, intelligence, pharmaceuticals and health care.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, MD Consult and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively. A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
About UniQuest Pty Limited www.uniquest.com.au
Established by The University of Queensland in 1984, UniQuest is widely recognised as one of Australia’s largest and most successful university commercialisation groups, benchmarking in the top tier of technology transfer worldwide. From an intellectual property portfolio of 1500+ patents it has created over 70 companies, and since 2000 UniQuest and its start-ups have raised more than A$450 million to take university technologies to market. Annual sales of products using UQ technology and licensed by UniQuest are running at A$3 billion. UniQuest now commercialises innovations developed at The University of Queensland and its commercialisation partner institutions: University of Technology Sydney, James Cook University, University of Tasmania, Mater Medical Research Institute, and Queensland Health.
A recent addition to the company is the Queensland Government-supported ilab technology business incubator and accelerator. UniQuest also provides access to an expansive and exclusive network of independent academics to tailor a consulting or project R&D solution to meet the diverse needs of industry and government, facilitating some 500 consulting, expert opinion, testing, and contract research services each year. UniQuest is also a leading Australasian provider of international development assistance recognised for excellence in technical leadership, management and research. Working with agencies such as AusAID, NZAID, the Asian Development Bank and the World Bank, UniQuest has developed and implemented more than 400 projects in 60+ countries throughout the Pacific, South-East Asia, the Indian sub-continent and Africa.
